[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590422":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":84,"collaborators":10,"id":88,"slug":89,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":10,"eligibilityCriteria":94,"healthyVolunteers":90,"sex":95,"minAge":96,"maxAge":97,"enrollmentInfo":98,"targetDuration":10,"studyType":101,"phases":10,"briefSummary":102,"conditions":103,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ARDS Patients for Training cohort",null,"Training cohort",[13],"Other: Not applicable- observational study",{"label":15,"type":10,"description":16,"interventionNames":17},"ARDS Patients for Validation cohort","Validation cohort",[13],[19],{"type":6,"name":20,"description":20,"armGroupLabels":21,"otherNames":10},"Not applicable- observational study",[9,15],[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Xiaojing Zou Zou","CONTACT","84+13995518630","249126734@qq.com",[29,47,61,70],{"facility":30,"status":31,"city":32,"state":33,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Department of Critical Care Medicine, Guangdong Provincial People's Hospital","RECRUITING","Guangzhou","Guangdong","China","CN",{"type":37,"coordinates":38},"Point",[39,40],113.25,23.11667,{"lat":40,"lon":39},[43],{"name":44,"role":25,"phone":45,"phoneExt":10,"email":46},"Yiyu Deng","86+15013287340","dengyiyu@gdph.org.cn",{"facility":48,"status":31,"city":49,"state":50,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Department of Critical Care Medicine, Renmin Hospital of Wuhan University","Wuhan","Hubei",{"type":37,"coordinates":52},[53,54],114.26667,30.58333,{"lat":54,"lon":53},[57],{"name":58,"role":25,"phone":59,"phoneExt":10,"email":60},"Liying Zhan","+8615327408448","zhanliying@whu.edu.cn",{"facility":62,"status":31,"city":49,"state":50,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":63,"geoPoint":65,"contacts":66},"Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Department of",{"type":37,"coordinates":64},[53,54],{"lat":54,"lon":53},[67],{"name":68,"role":25,"phone":69,"phoneExt":10,"email":27},"Xiaojing Zou","86+13995518630",{"facility":71,"status":31,"city":72,"state":73,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Department of Emergency, Zhongshan Hospital, Fudan University","Shanghai","Shanghai Municipality",{"type":37,"coordinates":75},[76,77],121.45806,31.22222,{"lat":77,"lon":76},[80],{"name":81,"role":25,"phone":82,"phoneExt":10,"email":83},"Zhenju Song","86+13816607453","song.zhenju@zs-hospital.sh.cn",{"type":85,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","XiaoJing Zou,MD","MD","100590422","electrical-impedance-tomography-based-prognostic-model-for-ards-100590422",false,"NCT06967207","Electrical Impedance Tomography-Based Prognostic Model for ARDS","Electrical Impedance Tomography-Based Prognostic Model for ARDS: A Multicenter, Prospective, Observational Study","Inclusion Criteria:\n\n1. Meet the new 2023 ARDS global definition;\n2. Age 18-80 years\n\nExclusion Criteria:\n\n1. Expected death within 24 hours of screening;\n2. Metastatic cancer (active malignancy with distant metastases);\n3. Severe psychiatric disorders;\n4. Pregnancy or postpartum status;\n5. Pneumothorax or moderate to large pleural effusion without adequate drainage;\n6. Chronic respiratory failure;\n7. Patients with pulmonary embolism or pulmonary hypertension;\n8. Heart failure patients: EF \\\u003C50% or NYHA class III or IV;\n9. Patient\u002Ffamily refusal to participate;\n10. Participation in another interventional trial within 3 months prior to enrollment","ALL","18 Years","80 Years",{"count":99,"type":100},625,"ESTIMATED","OBSERVATIONAL","This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.",[104,105],"Acute Respiratory Distress Syndrome (ARDS)","Ventilator-induced Lung Injury","2025-05-10",{"date":108,"type":109},"2025-05-13","ACTUAL",{"date":111,"type":109},"2025-04-15",{"date":113,"type":100},"2027-12-31",{"name":86,"class":6},4]